"This is the first time we've seen improvement in fibrosis that was observed in participants with compensated cirrhosis due ...

Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

May 8, 2025. More for You ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands.

It took a month, but this is the Phillies lineup that was advertised. They pounded the Rays on Wednesday to with their fourth ...

Some have been standing there for over an hour. The band that’s worth the wait? Brass Mash. Aptly named, Brass Mash is a local SLO County brass-instrument-based mash-up band. “It’s not a ...